4-(Trifluoromethoxy)pyridin-2-amine, 98+%, 100mg

3,4,5-Trifluoro-4'-(trans-4-propylcyclohexyl)-1,1'-biphenyl, 98.0%, 1g

6-Chloroimidazo[1,2-a]pyridine-3-carboxylic acid, 95.0%, 250mg

Estramustine, 98%, 250mg

N-Acetylcysteamine, 85.0%, 5g

(S)-4-(TERT-BUTYL)-2-(ISOQUINOLIN-1-YL)-4,5-DIHYDROOXAZOLE, 95%, 250mg

N,N'-Di(2-naphthyl)-N,N'-diphenyl-1,4-phenylenediamine>98.0%(HPLC)(N)1g

1,2,3,4-Thiatriazol-5-amine, 95.0%, 1g

NITROMETHANETRISPROPIONIC ACID, 97.0%, 25g

Sodium formate D, 99.5 at%D, 10 g, glass packaging

2-(2-BROMO-ETHYL)-[1,2]OXAZINANE, 95.0%, 2g

Decyl acrylate, 97% +(stabilized with MEHQ), 100mg

2,2-Difluoro-7-oxa-bicyclo[4.1.0]heptane, 97.0%, 1g